Early highly active antiretroviral therapy enhances B-cell longevity: a 5 year follow up.

Early highly active antiretroviral therapy enhances B-cell longevity: a 5 year follow up.

Item
http://www.wikidata.org/entity/Q42234700
Contrasting Adult and Infant Immune Responses to HIV Infection and VaccinationImmunization of children with secondary immunodeficiencyPremature B-cell senescence as a consequence of chronic immune activation.Early ART Results in Greater Immune Reconstitution Benefits in HIV-Infected Infants: Working with Data Missingness in a Longitudinal DatasetInfluence of the timing of antiretroviral therapy on the potential for normalization of immune status in human immunodeficiency virus 1-infected individuals.The influence of paediatric HIV infection on circulating B cell subsets and CXCR5(+) T helper cellsRates and risk factors associated with the progression of HIV to AIDS among HIV patients from Zhejiang, China between 2008 and 2012Prevalence and Persistence of Varicella Antibodies in Previously Immunized Children and Youth With Perinatal HIV-1 Infection.Predictors of Infant Age at Enrollment in Early Infant Diagnosis Services in Kenya.HIV-associated memory B cell perturbations.Downfall of the current antibody correlates of influenza vaccine response in yearly vaccinated subjects: Toward qualitative rather than quantitative assays.Antiretroviral treatment for HIV infection: Swedish recommendations 2016.
P2860

Early highly active antiretroviral therapy enhances B-cell longevity: a 5 year follow up.

Item
http://www.wikidata.org/entity/Q42234700
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Early highly active antiretroviral therapy enhances B-cell longevity: a 5 year follow up.
@en
Early highly active antiretroviral therapy enhances B-cell longevity: a 5 year follow up.
@nl
type
label
Early highly active antiretroviral therapy enhances B-cell longevity: a 5 year follow up.
@en
Early highly active antiretroviral therapy enhances B-cell longevity: a 5 year follow up.
@nl
prefLabel
Early highly active antiretroviral therapy enhances B-cell longevity: a 5 year follow up.
@en
Early highly active antiretroviral therapy enhances B-cell longevity: a 5 year follow up.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Early highly active antiretroviral therapy enhances B-cell longevity: a 5 year follow up.
@en
P2093
P304
P31
P356
10.1097/INF.0000000000000144
P433
P478
P50
P577
P698